EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Surface-engineered nanobeads for regioselective antibody binding: A robust immunoassay platform leveraging catalytic signal amplification

Jounghyun Yoo, Youngsun Kim, Ji Hyun Back, Jawon Shin, Pan Kee Bae, Kyung Mi Park, Myung Kim, Young Hun Seo, Yecheol Bak, Yoon Ho Heo, Jeongyun Heo, Honghwan Choi und 6 weitere

Biosensors and Bioelectronics · 2025

DOI: 10.1016/j.bios.2025.117463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Jounghyun Yoo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Chemical and Biological Integrative Research Center, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Biosensing Techniques, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Institute of Science and Technology, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulating protein interactions and protein corona formation of nanomaterials is crucial for advancing nanomedicine, where surface engineering of nanomaterials plays a pivotal role in precise control over biological interactions. Here, we present a surface-engineered nanoparticle-based immunoassay platform using carboxyl-enriched polystyrene nanobeads (CEPS) with regioselectively controlled antibody-binding properties. Proteomic analysis and theoretical simulation revealed that CEPS has an enhanced Fc-specific binding affinity for immunoglobulins compared to conventional carboxylated polystyrene beads, with a higher surface carboxyl density critically mediating protein interactions. This regioselective antibody binding with unique Fc-specific affinity eliminates the need for complex surface modifications, streamlining the assay process and broadening the applicability across various immunoassay formats. Additionally, incorporating a palladium catalyst within CEPS enables solvent-triggered on-demand catalytic signal amplification using a leucodye substrate, providing a more stable alternative to enzyme-based methods while significantly enhancing detection sensitivity and stability. The platform demonstrated enhanced performance in detecting clinically relevant biomarkers, including C-reactive protein, interferon-gamma, and the receptor-binding domain of SARS-CoV2, achieving lower detection limits and faster response times compared to conventional enzyme-based ELISA systems. Notably, the CEPS-based assay retained catalytic activity for over 140 days at room temperature, underscoring its potential for reliable, long-term use in diverse diagnostic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Biosensing TechniquesNanoparticlesAntibodiesHumansPolystyrenesImmunoassayLimit of DetectionCatalysisC-Reactive ProteinPalladium

Stichwörter der Autor:innen

Carboxyl-enriched polystyrene nanobeadPalladium catalystRegioselective antibody bindingimmunoassay

Substanzen

PolystyrenesC-Reactive ProteinPalladiumAntibodies

Autor:innen und Institutionen

  • Chemical and Biological Integrative Research Center, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • HGUARD Inc., Daejeon, 34054, Republic of Korea.
  • BioNano Health Guard Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
  • Chemical and Biological Integrative Research Center, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea; Biosensor Group, Korea Institute of Science and Technology Europe, Campus E7.1, Saarbrücke…
  • Chemical and Biological Integrative Research Center, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 028…
  • KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.

Förderung

  • Korea Institute of Science and Technology
  • National Research Foundation of Korea

Zitieren

APA

Yoo, J., Kim, Y., Back, J. H., Shin, J., Bae, P. K., Park, K. M., Kim, M., Seo, Y. H., Bak, Y., Heo, Y. H., Heo, J., Choi, H., Kim, Y., Lee, S., Lee, J. E., Jeong, S., Yang, J. K., & Kim, S. (2025). Surface-engineered nanobeads for regioselective antibody binding: A robust immunoassay platform leveraging catalytic signal amplification. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117463

Vancouver

Yoo J, Kim Y, Back JH, Shin J, Bae PK, Park KM, et al. Surface-engineered nanobeads for regioselective antibody binding: A robust immunoassay platform leveraging catalytic signal amplification. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117463

BibTeX
@article{Yoo2025,
  author = {Yoo, Jounghyun and Kim, Youngsun and Back, Ji Hyun and Shin, Jawon and Bae, Pan Kee and Park, Kyung Mi and Kim, Myung and Seo, Young Hun and Bak, Yecheol and Heo, Yoon Ho and Heo, Jeongyun and Choi, Honghwan and Kim, Yongju and Lee, Sangyoup and Lee, Ji Eun and Jeong, Sohdam and Yang, Jin-Kyoung and Kim, Sehoon},
  title = {Surface-engineered nanobeads for regioselective antibody binding: A robust immunoassay platform leveraging catalytic signal amplification},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  doi = {10.1016/j.bios.2025.117463}
}
Kostenlos starten →